What Is Quality by Design and Why Pharma Relies on ItUntitledBuilt for Luxembourg's Life Sciences Teams
Quality by Design (QbD) training in Luxembourg gives pharmaceutical and biopharmaceutical professionals a systematic, science-based way to build quality into a product from the design stage instead of testing it in at the end. Grounded in the ICH Q8(R2), Q9, Q10 and Q11 guidelines that the FDA and EMA increasingly expect in modern submissions, this course turns QbD from theory into daily practice. Over a focused one-day programme you learn to define the Quality Target Product Profile, identify Critical Quality Attributes, run risk assessment, use Design of Experiments to map the design space, and build a robust control strategy. It suits formulation and analytical scientists, process development engineers, quality assurance teams and regulatory affairs (CMC) specialists across Luxembourg's growing life sciences sector. With EU-aligned regulators and a busy CDMO and biomanufacturing base on your doorstep, now is a strong time to make QbD part of how you develop and manufacture medicines.










